Aclaris Therapeutics Inc. (ACRS)
NASDAQ: ACRS
· Real-Time Price · USD
1.33
-0.03 (-2.21%)
At close: Apr 29, 2025, 3:59 PM
1.32
-1.12%
After-hours: Apr 29, 2025, 07:10 PM EDT
Aclaris Therapeutics Revenue
Aclaris Therapeutics reported an annual revenue of $18.72M, reflecting a -40.09% growth. For the quarter ending December 31, 2024, Aclaris Therapeutics generated $9.21M in revenue.
Revenue (ttm)
$18.72M
Revenue Growth
-40.09%
Price / Sales Ratio
10.24
Revenue / Employee
$306.89K
Employees
61
Market Cap
144.56M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | % Change |
|---|---|---|
| Dec 31, 2024 | 18.72M | -40.09% |
| Dec 31, 2023 | 31.25M | +5.03% |
| Dec 31, 2022 | 29.75M | +340.05% |
| Dec 31, 2021 | 6.76M | +4.30% |
| Dec 31, 2020 | 6.48M | n/a |